Company Disclosure

Inventurus Knowledge Solutions Limited (Scrip Code: 544309, NSE Symbol: IKS) submitted a regulatory filing pursuant to Regulation 30 of SEBI LODR Regulations, 2015, dated June 30, 2026, signed by Company Secretary and Compliance Officer Sameer S Chavan (Membership No. F7211).

Investment Details

  • Total Approved Investment: $15 million equity infusion approved until March 31, 2029
  • Immediate Investment: $3 million to be invested up to July 3, 2026
  • Current Investment: $17 million as of June 2026
  • Expected Total Investment: $32 million by 2029
  • Near-term Investment: Approximately $5 million
  • Ownership Impact: Immediate investment will make IKS the majority owner of WWMG

Use of Funds

The capital infusion is strategically allocated for:

  • Physician hiring and recruitment
  • Value-Based Care (VBC) expansion
  • General working capital support
  • Expansion of physician practice operations

Operational Progress

Physician Recruitment

  • 13 recently acquired physicians currently in initial ramp-up stage
  • Recruitment for additional 9 doctors planned for the next 6 months

Platform Implementation

  • Platform adoption nearly complete following resolution of initial Epic access challenges
  • As of June 2026: 95% of clinicians successfully onboarded onto Scribble platform
  • Operational technologies: Virtual Clinic Assistant, Referral Management, and My Care Hub
  • Ongoing technical specification updates for EVE - Prior Authorization data compatibility issues

Performance Metrics

Operational Efficiency

  • Days Sales Outstanding (DSO) reduced from 46.1 days to 41.7 days through Revenue Cycle Management optimization

Cost Management

  • Actions taken will result in $2.5 million annualized savings in the upcoming year

Performance Growth

  • Visit counts increased by 3% from April to May 2026 as platform implementation accelerated
  • All VBC agreements have been renegotiated to contribute to future revenue growth

Strategic Benefits

  • WWMG serves as powerful brand ambassador and reference site, enhancing market credibility
  • WWMG's endorsement directly facilitated securing full platform deals with similar physician-led multi-speciality groups
  • Enabled organization to obtain license as an Accountable Care Organization (ACO) convenor
  • WWMG continues to be a top 10 customer for IKS

Financial Impact

Return on investment is along expected lines and in line with the company's overall business ROE. The organization anticipates growth as clinical practices reach maturity, leading to increased operating leverage and projected rise in IKS platform services revenue.